291
Views
0
CrossRef citations to date
0
Altmetric
Corrigendum

Corrigendum

This article refers to:
Warfarin treatment and risk of stroke among primary care patients with atrial fibrillation

Wändell P, Carlsson AC, Holzmann MJ, et al. Warfarin treatment and risk of stroke among primary care patients with atrial fibrillation. Scand Cardiovasc J. http://dx.doi.org/10.1080/14017431.2016.1215519

When the above article was first published online, the result in the abstract was “Persistent treatment with warfarin was present among 33.7% of women and 40.0% among men. Persistent warfarin treatment, compared to no persistent treatment, was associated with a stroke preventing effect with fully adjusted HRs of 0.25 (95%CI 0. 0.26–0.45) in women, and 0.25 (95%CI 0.28–0.43) in men”. This has now been corrected to “Persistent treatment with warfarin was present among 33.7% of women and 40.0% among men. Persistent warfarin treatment, compared to no persistent treatment, was associated with a stroke preventing effect with fully adjusted HRs of 0.25 (95%CI 0.18–0.36) in women, and 0.25 (95%CI 0.19–0.32) in men”.

The authors apologise for this error.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.